In the 1990s, Phil Gomez recalls the UK government launching what would be akin to a quasi-Operation Warp Speed in today’s parlance, as the region was facing high cases of meningitis C in children under the age of 5. The chemical engineer by training was working at North American Vaccine and helped the company launch … Continue reading ‘Perfect time’: SIGA’s CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play